Genta Saito is a Principal of the Carlyle Japan buyout advisory team. He is based in Tokyo.
Since joining Carlyle in 2006, Mr. Saito has advised seven portfolio companies including CureApp, Inc., Solasto Corp. (formerly N.I.C.Corp), Oyatsu Company, Ltd., and Orion Breweries, Ltd.
Prior to joining Carlyle, Mr. Saito spent five years at Nishimura & Partners, one of the Big Four law firms in Japan, covering various aspects of corporate activities including M&A transactions. He is admitted to practice law in Japan and New York State.
Mr. Saito received his M.B.A. from INSEAD, LL.M. in corporate law from New York University and LL.B. from the University of Tokyo. He serves on the Board of Directors of CureApp, Inc.